Ori Biotech

Manufacturing brighter futures for cell and gene therapy patients

Ori Biotech was founded in 2015, is headquartered in London, United Kingdom, lists 11–50 employees, and has $139.4M in recorded funding across 3 rounds.

Headquarters
London
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$139.4M
Last Round
$100.0M Series BJan 2022
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Ori Biotech is a London and Philadelphia-based manufacturing technology company on a mission to enable widespread patient access to life-saving cell and gene therapies. The company has developed the IRO platform, a closed-loop, automated CGT manufacturing system that takes a biology-first approach — combining superior biological performance with digitally enabled automation. By automating manual steps, deskilling complex processes, and providing cloud-native process intelligence, Ori enables high-throughput, high-quality, and lower-cost manufacturing essential for reaching commercial scale. Founded in 2015 by Dr. Farlan Veraitch, Ori has assembled a team with over 200 years of combined pharmaceutical, CGT, and venture-building experience.

Summary

Ori Biotech is a Biotech company based in London, United Kingdom, founded in 2015. It lists 11–50 employees. It has raised $139.4M in total across 3 rounds, most recently a $100.0M Series B round in Jan 2022. Investors include Northpond Ventures, Octopus Ventures and Kenneth Chien / Novalis LifeSciences.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2022
$100.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ori Biotech on Indexed.vc
<a href="https://indexed.vc/companies/ori-biotech"><img src="https://indexed.vc/api/badge/company/ori-biotech" alt="Ori Biotech on Indexed.vc" width="260" height="76" /></a>